View : 522 Download: 0
Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants
- Title
- Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants
- Authors
- Kwak H.W.; Park H.-J.; Jung S.-Y.; Oh E.Y.; Park S.-I.; Kim Y.; Park S.; Kim Y.-J.; Ko H.L.; Lee J.-A.; Won H.; Hwang Y.-H.; Kim S.Y.; Kim S.E.; Bae S.E.; Yoon M.; Kim J.-O.; Song M.; Lee S.J.; Seo K.-W.; Lee K.; Kim D.; Kim H.; Lee S.-M.; Hong S.-H.; Nam J.-H.
- Ewha Authors
- 홍소희
- SCOPUS Author ID
- 홍소희
![scopus](/images/layout/icon2.png)
- Issue Date
- 2023
- Journal Title
- Vaccine
- ISSN
- 0264-410X
- Citation
- Vaccine vol. 41, no. 11, pp. 1892 - 1901
- Keywords
- Measles virus vector; Neutralizing antibody; SARS-CoV-2
- Publisher
- Elsevier Ltd
- Indexed
- SCIE; SCOPUS
![scopus](/images/layout/scopus2.gif)
- Document Type
- Article
- Abstract
- Owing to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants, the development of effective and safe vaccines has become a priority. The measles virus (MeV) vaccine is an attractive vaccine platform as it has been administered to children for more than 40 years in over 100 countries. In this study, we developed a recombinant MeV expressing the full-length SARS-CoV-2 spike protein (rMeV-S) and tested its efficacy using mouse and hamster models. In hCD46Tg mice, two-dose rMeV-S vaccination induced higher Th1 secretion and humoral responses than one-dose vaccination. Interestingly, neutralizing antibodies induced by one-dose and two-dose rMeV-S immunization effectively blocked the entry of the α, β, γ, and δ variants of SARS-CoV-2. Furthermore, two-dose rMeV-S immunization provided complete protection against SARS-CoV-2 in the hamster model. These results suggest the potential of rMeV-S as a vaccine candidate for targeting SARS-CoV-2 and its variants. © 2023 Elsevier Ltd
- DOI
- 10.1016/j.vaccine.2023.02.005
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML